Literature DB >> 15039148

Glucocorticoids modulate amino acid-induced translation initiation in human skeletal muscle.

Zhenqi Liu1, Guolian Li, Scot R Kimball, Linda A Jahn, Eugene J Barrett.   

Abstract

Amino acids are unique anabolic agents in that they nutritively signal to mRNA translation initiation and serve as substrates for protein synthesis in skeletal muscle. Glucocorticoid excess antagonizes the anabolic action of amino acids on protein synthesis in laboratory animals. To examine whether excessive glucocorticoids modulate mixed amino acid-signaled translation initiation in human skeletal muscle, we infused an amino acid mixture (10% Travasol) systemically to 16 young healthy male volunteers for 6 h in the absence (n = 8) or presence (n = 8) of glucocorticoid excess (dexamethasone 2 mg orally every 6 h for 3 days). Vastus lateralis muscles were biopsied before and after amino acid infusion, and the phosphorylation of eukaryotic initiation factor (eIF) 4E-binding protein 1 (4E-BP1), ribosomal protein S6 kinase (p70(S6K)), and eIF2alpha and the guanine nucleotide exchange activity of eIF2B were measured. Systemic infusion of mixed amino acids significantly stimulated the phosphorylation of 4E-BP1 (P < 0.04) and p70(S6K) (P < 0.001) and the dephosphorylation of eIF2alpha (P < 0.003) in the control group. Dexamethasone treatment did not alter the basal phosphorylation state of 4E-BP1, p70(S6K), or eIF2alpha; however, it abrogated the stimulatory effect of amino acid infusion on the phosphorylation of 4E-BP1 (P = 0.31) without affecting amino acid-induced phosphorylation of p70(S6K) (P = 0.002) or dephosphorylation of eIF2alpha (P = 0.003). Neither amino acid nor dexamethasone treatment altered the guanine nucleotide exchange activity of eIF2B. We conclude that changes of amino acid concentrations within the physiological range stimulate mRNA translation by enhancing the binding of mRNA to the 43S preinitiation complex, and the activity of p70(S6K) and glucocorticoid excess blocks the former action in vivo in human skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039148     DOI: 10.1152/ajpendo.00457.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  10 in total

Review 1.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

2.  Therapeutic Benefit of Autophagy Modulation in Pompe Disease.

Authors:  Jeong-A Lim; Baodong Sun; Rosa Puertollano; Nina Raben
Journal:  Mol Ther       Date:  2018-05-03       Impact factor: 11.454

3.  Transforming growth factor-beta induces airway smooth muscle hypertrophy.

Authors:  Adam M Goldsmith; J Kelley Bentley; Limei Zhou; Yue Jia; Khalil N Bitar; Diane C Fingar; Marc B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-20       Impact factor: 6.914

4.  Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats.

Authors:  O Schakman; S Kalista; L Bertrand; P Lause; J Verniers; J M Ketelslegers; J P Thissen
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

5.  Effects of fatty acid treatments on the dexamethasone-induced intramuscular lipid accumulation in chickens.

Authors:  Xiao juan Wang; Dai lin Wei; Zhi gang Song; Hong chao Jiao; Hai Lin
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

6.  Dietary supplementation with shiikuwasha extract attenuates dexamethasone-induced skeletal muscle atrophy in aged rats.

Authors:  Yasuyuki Sakata; Tomoyuki Okamoto; Kazutaka Oshio; Hirohiko Nakamura; Hiroshi Iwamoto; Kazuyoshi Namba; Yasuhiro Takeda; Fumiaki Yoshizawa
Journal:  Springerplus       Date:  2016-06-21

7.  Modulation of mTOR signaling as a strategy for the treatment of Pompe disease.

Authors:  Jeong-A Lim; Lishu Li; Orian S Shirihai; Kyle M Trudeau; Rosa Puertollano; Nina Raben
Journal:  EMBO Mol Med       Date:  2017-03       Impact factor: 12.137

Review 8.  Nutrients against Glucocorticoid-Induced Muscle Atrophy.

Authors:  Min-Kyeong Lee; Hyeon Hak Jeong; Myeong-Jin Kim; Heeyeon Ryu; Jiwon Baek; Bonggi Lee
Journal:  Foods       Date:  2022-02-25

9.  Detecting the Effects of the Glucocorticoid Dexamethasone on Primary Human Skeletal Muscle Cells-Differences to the Murine Cell Line.

Authors:  Eva K Langendorf; Pol M Rommens; Philipp Drees; Stefan G Mattyasovszky; Ulrike Ritz
Journal:  Int J Mol Sci       Date:  2020-04-03       Impact factor: 5.923

10.  Pyropia yezoensis Protein Supplementation Prevents Dexamethasone-Induced Muscle Atrophy in C57BL/6 Mice.

Authors:  Min-Kyeong Lee; Jeong-Wook Choi; Youn Hee Choi; Taek-Jeong Nam
Journal:  Mar Drugs       Date:  2018-09-11       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.